Petros Pharmaceuticals (PTPI) announces a new collaboration with Lemonaid Health, telemedicine provider and a subsidiary of 23andMe (ME), serving hundreds of thousands of patients with quality healthcare. As part of the collaboration, prescription STENDRA in all strengths will be available through Lemonaid Health’s telehealth platform. This collaboration allows Lemonaid Health to work directly with Petros, resulting in expanded distribution, and better access for patients.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTPI: